1. Home
  2. CARM vs KDLY Comparison

CARM vs KDLY Comparison

Compare CARM & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • KDLY
  • Stock Information
  • Founded
  • CARM 2016
  • KDLY 2019
  • Country
  • CARM United States
  • KDLY United States
  • Employees
  • CARM N/A
  • KDLY N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • KDLY
  • Sector
  • CARM Health Care
  • KDLY
  • Exchange
  • CARM Nasdaq
  • KDLY NYSE
  • Market Cap
  • CARM 19.7M
  • KDLY 19.6M
  • IPO Year
  • CARM N/A
  • KDLY 2024
  • Fundamental
  • Price
  • CARM $0.45
  • KDLY $2.47
  • Analyst Decision
  • CARM Hold
  • KDLY
  • Analyst Count
  • CARM 5
  • KDLY 0
  • Target Price
  • CARM $4.57
  • KDLY N/A
  • AVG Volume (30 Days)
  • CARM 512.7K
  • KDLY 13.0M
  • Earning Date
  • CARM 03-31-2025
  • KDLY 03-04-2025
  • Dividend Yield
  • CARM N/A
  • KDLY N/A
  • EPS Growth
  • CARM N/A
  • KDLY N/A
  • EPS
  • CARM N/A
  • KDLY N/A
  • Revenue
  • CARM $20,268,000.00
  • KDLY $2,875,400.00
  • Revenue This Year
  • CARM $46.34
  • KDLY N/A
  • Revenue Next Year
  • CARM N/A
  • KDLY N/A
  • P/E Ratio
  • CARM N/A
  • KDLY N/A
  • Revenue Growth
  • CARM 41.13
  • KDLY N/A
  • 52 Week Low
  • CARM $0.38
  • KDLY $0.65
  • 52 Week High
  • CARM $2.77
  • KDLY $5.25
  • Technical
  • Relative Strength Index (RSI)
  • CARM 44.17
  • KDLY N/A
  • Support Level
  • CARM $0.43
  • KDLY N/A
  • Resistance Level
  • CARM $0.50
  • KDLY N/A
  • Average True Range (ATR)
  • CARM 0.05
  • KDLY 0.00
  • MACD
  • CARM 0.00
  • KDLY 0.00
  • Stochastic Oscillator
  • CARM 28.16
  • KDLY 0.00

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: